Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-23
2005-08-23
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S234000
Reexamination Certificate
active
06933297
ABSTRACT:
A compound, 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione, its (−) enantiomer, its (+) enantiomer, pharmaceutically-acceptable salts thereof, a method for treating pain comprising administering a pain-ameliorating effective amount of the (−) enantiomer to an individual suffering from pain and pharmaceutical compositions containing the (−) enantiomer are disclosed.
REFERENCES:
patent: 2003/0153571 (2003-08-01), Brown et al.
patent: 2004/0053929 (2004-03-01), Brown et al.
patent: 0736531 (1996-10-01), None
patent: WO 9511244 (1995-04-01), None
patent: WO 0147524 (2001-07-01), None
Alford Vernon
Bare Thomas
Barlaam Christine
Brown Dean Gordon
Horchler Carey Lynn
AstraZeneca AB
Bernhardt Emily
Mitchell Kenneth F.
LandOfFree
7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyr... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyr..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyr... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3465642